Open Access
- 6 April 2023
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 17 (1) , 1-5
Abstract
Background: There are three main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose, and throat). Leishmaniasis is caused by protozoan parasites, which are transmitted by the bite of infected female phlebotomine sandflies. The disease affects some of the world’s poorest people and is associated with malnutrition, population displacement, poor housing, a weak immune system, and lack of financial resources. An estimated 700,000 to 1 million new cases occur annually. Only a small fraction of those infected by parasites causing leishmaniasis will eventually develop the disease. We report a case of exclusive lymph node involvement in leishmaniasis, presenting as localized lymphadenopathies. The diagnosis of lymphatic leishmaniasis was confirmed by the presence of Leishmania donovani bodies in fine needle aspiration cytology, and positive anti-rK39 antibodies. The bone marrow aspiration was negative for Leishmania donovani bodies. Abdominal ultrasound was done and there was no organomegaly. Furthermore, localized lymphadenopathies may provide a diagnostic challenge by clinically mimicking a lymphoma or other causes of lymphadenopathy. Due to its rarity and its tendency to pose a clinical diagnostic challenge, we decided to report a case of lymphatic leishmaniasis. Case presentation: A 12-year-old Amara male patient presented to the University of Gondar comprehensive specialized hospital, Northwestern Ethiopia, with six discrete right lateral cervical lymphadenopathies, the largest measuring 3 × 2 cm2, with no cutaneous lesion. Fine needle aspiration cytology confirmed the diagnosis of leishmaniasis in lymph node, and he was put on sodium stibogluconate (20 mg/kg body weight/day) and paromomycin (15 mg/kg body weight/day) injections, which are given intramuscularly for 17 days. Having completed his medication at the University of Gondar comprehensive specialized hospital, he had a smooth course and was discharged with appointment scheduled for follow-up after 3 months. Conclusion: In the clinical evaluation of a patient with isolated lymphadenopathies, leishmaniasis must be considered as a differential diagnosis in immunocompetent subjects in endemic areas for early diagnostic workup and management.Keywords
This publication has 16 references indexed in Scilit:
- Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain)Clinical Microbiology and Infection, 2015
- Localized Leishmanial Lymphadenopathy: An Unusual Manifestation of Leishmaniasis in a Traveler in Southern EuropeVector-Borne and Zoonotic Diseases, 2011
- Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an exampleCellular Microbiology, 2008
- Laboratory Diagnosis of Visceral LeishmaniasisClinical and Vaccine Immunology, 2002
- LeishmaniasisThe Lancet, 1999
- Necrotizing and suppurative lymphadenitis in Leishmania major infectionsTropical Medicine & International Health, 1996
- Localized Leishmania Lymphadenitis:Immunohistochemical StudiesAmerican Journal of Clinical Pathology, 1994
- Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.Journal of Clinical Investigation, 1989
- Lymphatic leishmaniasis in IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Localized Leishmaniasis of Lymph NodesBMJ, 1958